Immunomodulatory Action of an Ayurvedic Polyherbal Formulation Maharishi Amrit Kalash-A Scoping Review
DOI:
https://doi.org/10.35652/IGJPS.2025.15001Keywords:
Maharishi Amrit Kalash, Ayurveda, scoping review, Rasayana, Antioxidant, immunomodulationAbstract
Background: Maharishi Amrit Kalash (MAK) is a polyherbal formulation of Ayurveda with potential immunomodulatory properties. While previous studies have explored its effects, the overall evidence base remains fragmented and inconclusive. This scoping review aims to map the existing literature on MAK, identify research gaps, and inform future research directions to elucidate its potential role in the immune system.
Objective: This scoping review aims to comprehensively identify gaps in current understanding and methodically survey the existing literature on the immunomodulatory effects of Maharishi Amrit Kalash (MAK) through a synthesis of preclinical and clinical studies to provide direction for future research.
Methods: Following PRISMA guidelines, a systematic search of relevant databases was conducted to identify studies investigating MAK's impact on immune function. Inclusion criteria encompassed preclinical and clinical studies evaluating MAK's effects on lymphoproliferative response, and other relevant immune parameters. While research published in other language than English, new reports, unpublished reports were excluded.
Results: A total of 81 studies were found eligible to be reviewed. Out of which only 11 fulfilled the inclusion criteria. Preclinical studies, particularly in murine models, demonstrated enhanced macrophage activity, splenic lymphocyte proliferation, and cytokine production following MAK administration. Clinical trials, including a prospective double-blind, placebo-controlled trial and a study involving 500 individuals, revealed promising outcomes such as significant reductions in allergy symptom scores and improvements in overall well-being, as well as a reduced incidence of colds in the MAK group compared to controls.
Discussion: MAK comes under Rasayana category is recognized for its immunomodulatory properties published in several journals. The preclinical and clinical studies showed that it has promising role in enhancing the macrophage function and lymphoproliferative response that boosts the immunity. Its use over 38 years in several countries also validated its safety and efficacy as an immunomodulatory agent.
Conclusion: The findings of this scoping review highlight the potential of Maharishi Amrit Kalash as an immunomodulatory agent in traditional Ayurvedic medicine. However, further investigation through extensive randomized clinical trials is warranted to conclusively establish its efficacy and safety profile. This review underscores the importance of exploring MAK's immunomodulatory effects in depth to inform clinical practice and public health strategies. © 2024 Caproslaxy Media. All rights reserved.
Metrics
References
Nicholson, Lindsay B. The immune system. Essays in Biochemistry 60, 275-301 (2016). https://doi.org/10.1042/ebc20160017
Hadden, J. W. Classification of immunotherapeutic agents. Dev Biol Stand 77, 5-15 (1992).
Bonilla, F. A. & Oettgen, H. C. Adaptive immunity. Journal of Allergy and Clinical Immunology 125, S33-S40 (2010). https://doi.org/10.1016/j.jaci.2009.09.017
Tulchinsky, T. H., Varavikova, E. & Bickford, J. D. The new public health. Third edition. edn, (Elsevier/AP, 2014).
Guo, J. et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 7, 391 (2022). https://doi.org/10.1038/s41392-022-01251-0
Strzelec, M., Detka, J., Mieszczak, P., Sobocinska, M. K. & Majka, M. Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front Immunol 14, 1127704 (2023). https://doi.org/10.3389/fimmu.2023.1127704
Pandey, M. M., Rastogi, S. & Rawat, A. K. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med 2013, 376327 (2013). https://doi.org/10.1155/2013/376327
Singh, R., Goel, S., Bourgeade, P., Aleya, L. & Tewari, D. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environ Sci Pollut Res Int 28, 55925-55951 (2021). https://doi.org/10.1007/s11356-021-16280-5
Chulet, R. & Pradhan, P. A Review on Rasayana. Phcog Rev. 3, 229-234 (2009).
Puradkar, G. S. Concept of Rasayana Chikitsa w. s. r. to Charaka Samhita. Ayurline: International Journal of Research in Indian Medicine 1, 32-38 (2017). https://doi.org/https://doi.org/10.52482/ayurline.v1i01.35
Thakur, M., Bhargava, S. & Dixit, V. K. Immunomodulatory Activity of Chlorophytum borivilianum Sant. F. Evid Based Complement Alternat Med 4, 419-423 (2007). https://doi.org/10.1093/ecam/nel094
Rastogi, S., Lakhotia, S. C. & Singh, R. H. in Translational Ayurveda Ch. Chapter 6, 77-99 (2019).
Sharma, H. M., Hanna, A. N., Titterington, L. C., Lubow, G. P. & Stephens, R. E. in Scientific Conference on Atherosclerosis, Thrombosis, and Proliferation. (American Heart Association).
Zanella, I., Lorenzo, R. D. & Lorenzo, D. D. Effects of the Dietary Supplement MAK4 on Oxidative Stress Parameters: A “Three-Cases” Report. OALib 02, 1-8 (2015). https://doi.org/10.4236/oalib.1102150
Tomlinson, J. P. & Wallace, R. Superoxide scavenging of two natural products, Maharishi -4 (M-4) and Maharishi 5 (M-5). Fed. Am. Soc. Exp. Biol. J. 5, A1284 (1991).
Blasdell, K., Sharma, H., Tomlinson, P. & Wallace, R. Subjective survey, blood chemistry and complete blood profile of subjects taking Maharishi Amrit Kalash (MAK). Fed. Am. Soc. Exp. Biol. J. 5, A1317 (1991).
Dwivedi, C., Agrawal, P., Natarajan, K. & Sharma, H. Antioxidant and Protective Effects of Amrit Nectar Tablets on Adriamycin- and Cisplatin-Induced Toxicities. The Journal of Alternative and Complementary Medicine 11, 143-148 (2005). https://doi.org/10.1089/acm.2005.11.143
Glaser, J. L. Maharishi Ayurveda: An introduction to recent research. Modern Science and Vedic Science 2, 89-108 (1988).
Engineer, F. N., Sharma, H. & Dwivedi, C. Protective effects of M-4 and M-5 on adriamycin induced microsomal lipid peroxidation and mortality. Biochem. Arch. 8, 267-272 (1992).
Glaser, J. L. & Moriarty, T. Prospective Study of Health Improvements in Users of Maharishi Amrit Kalash 5. Proceedings of the American Association of Ayurvedic Medicine 7, 4 (1991).
Dileepan, K. N., Varghese, S. T., Page, J. C. & Stechschulte, D. J. Enhanced lymphoproliferative response, macrophage mediated tumor cell killing and nitric oxide production after ingestion of an ayurvedic drug. Biochem. Arch. 9, 365-374 (1993).
Glaser, J., Robinson, D. & Wallace, R. Improvement in Seasonal Respiratory Allergy with Maharishi Amrit Kalash 5, an Ayurvedic Herbal Immunomodulator. Seventh Annual Conference on Scientific Proceedings of the American Association of Ayurvedic Medicine 7, 6 (1991).
Misra, N. et al. in XVI International Cancer Congress, Abs Book. 287–288.
Samaiya, A. et al. Reduction in toxicity of cancer chemotherapy by Maharishi Amrit Kalash (MAK)- An ayurvedic herbal compound. Ann. Natl. Acad. Med. Sci. (India) (Online) 35, 109-119 (1999).
Saxena, A. et al. An ayurvedic herbal compound to reduce toxicity to cancer chemotherapy: A randomized controlled trial. Indian J. Med. Paediatr. Oncol. 29, 11–18 (2008).
Dogra, J., Grover, N., Kumar, P. & Aneja, N. Indigenous free radical scavenger MAK 4 and 5 in angina pectoris. Is it only a placebo? J Assoc Physicians India 42, 466-467 (1994).
Dogra, J. & Bhargava, A. Lipid peroxide in ischemic heart disease (IHD): Inhibition by Maharishi Amrit Kalash (MAK-4 and MAK-5) Herbal Mixtures. Fed. Am. Soc. Exp. Biol. J. 14, A121 (2000).
Sharma, H. M., Feng, Y. & Panganamala, R. V. Maharishi Amrit Kalash (MAK) prevents human platelet aggregation. Clinica e Terapia Cardiovascolare 8, 227-230 (1989).
Sharma, H. M., Hanna, A. N., Kauffman, E. M. & Newman, H. A. I. Inhibition of human low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures. Pharmacology Biochemistry and Behavior 43, 1175-1182 (1992). https://doi.org/10.1016/0091-3057(92)90500-f
Arksey, H. & O'Malley, L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology 8, 19-32 (2005). https://doi.org/10.1080/1364557032000119616
Mak, S. & Thomas, A. Steps for Conducting a Scoping Review. Journal of Graduate Medical Education 14, 565-567 (2022). https://doi.org/10.4300/jgme-d-22-00621.1
Munn, Z. et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology 18 (2018). https://doi.org/10.1186/s12874-018-0611-x
Patel, V., Dileepan, K., Stechschulte, D. & Sharma, H. Enhancement of lymphoproliferative responses by Maharishi Amrit Kalash (MAK) in rats. Fed. Am. Soc. Exp. Biol. J. 2, 4740 (1988).
Dileepan, K. N., Patel, V., Sharma, H. M. & Stechschulte, D. J. Priming of splenic lymphocytes after ingestion of an ayurvedic herbal food supplement: Evidence for an immunomodulatory effect. Biochem. Arch. 6, 267-274 (1990).
Inaba, R., Sugiura, H. & Iwata, H. Immunomodulatory Effects of Maharishi Amrit Kalash 4 and 5 in Mice. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) 50, 901-905 (1995). https://doi.org/10.1265/jjh.50.901
Inaba, R., Sugiura, H., Iwata, H., Mori, H. & Tanaka, T. Immunomodulation by Maharishi Amrit Kalash 4 in mice. Hum. Nutr. Appl. Nutr. 48, 10-21 (1996).
Inaba, R., Sugiura, H., Iwata, H. & Tanaka, T. Dose-dependent activation of immune function in mice by ingestion of Maharishi Amrit Kalash 4. Environmental Health and Preventive Medicine 2, 126-131 (1997). https://doi.org/10.1007/bf02931978
Inaba, R., Sugiura, H., Iwata, H. & Tanaka, T. Dose-dependent activation of immune function in mice by ingestion of Maharishi Amrit Kalash 5. Environmental Health and Preventive Medicine 2, 35-39 (1997). https://doi.org/10.1007/bf02931227
Sugiura, H., Inaba, R., Iwata, H., Nishida, H. & Tanaka, T. Modifying effects of maharishi amrit kalash 4 and 5 on phagocytic and digestive functions of macrophages in male icr mice. Environmental Health and Preventive Medicine 3, 50-54 (1998). https://doi.org/10.1007/bf02931239
Inaba, R., Mirbod, S. M. & Sugiura, H. Effects of Maharishi Amrit Kalash 5 as an Ayurvedic herbal food supplement on immune functions in aged mice. BMC Complementary and Alternative Medicine 5 (2005). https://doi.org/10.1186/1472-6882-5-8
Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal Transduction and Targeted Therapy 8 (2023). https://doi.org/10.1038/s41392-023-01452-1
Yang, S., Zhao, M. & Jia, S. Macrophage: Key player in the pathogenesis of autoimmune diseases. Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1080310
Guerriero, J. L. in Biology of T Cells - Part B International Review of Cell and Molecular Biology 73-93 (2019).
Devanabanda, M. et al. Immunomodulatory effects of copper nanoparticles against mitogen-stimulated rat splenic and thymic lymphocytes. Food and Chemical Toxicology 184 (2024). https://doi.org/10.1016/j.fct.2023.114420
Jayaraman, S. & Variyar, J. in Plant Metabolites: Methods, Applications and Prospects Ch. Chapter 18, 441-464 (2020).
Wang, P. et al. Functional Component Isolated from Phaseolus vulgaris Lectin Exerts In Vitro and In Vivo Anti-Tumor Activity through Potentiation of Apoptosis and Immunomodulation. Molecules 26 (2021). https://doi.org/10.3390/molecules26020498
Lee, C.-H., Kim, J.-K., Kim, H.-Y., Park, S.-M. & Lee, S.-M. Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo. International Immunopharmacology 9, 1555-1561 (2009). https://doi.org/10.1016/j.intimp.2009.09.011
Naik, S. et al. Biochemical characterisation of lectin from Indian hyacinth plant bulbs with potential inhibitory action against human cancer cells. International Journal of Biological Macromolecules 105, 1349-1356 (2017). https://doi.org/10.1016/j.ijbiomac.2017.07.170
Chakraborty, P., Chatterjee, M., Chakraborty, A., Padma, S. & Mukherjee, S. in Medicinal Plants and Antimicrobial Therapies Ch. Chapter 3, 49-83 (2024).
Hirayama, D., Iida, T. & Nakase, H. The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. International Journal of Molecular Sciences 19 (2017). https://doi.org/10.3390/ijms19010092
Gierlikowska, B., Gierlikowski, W. & Demkow, U. Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions. Frontiers in Pharmacology 11 (2020). https://doi.org/10.3389/fphar.2020.01339
Nakamizo, S. et al. Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. Journal of Clinical Investigation 133 (2023). https://doi.org/10.1172/jci171088
Ryan, D. G. & O'Neill, L. A. J. Krebs Cycle Reborn in Macrophage Immunometabolism. Annual Review of Immunology 38, 289-313 (2020). https://doi.org/10.1146/annurev-immunol-081619-104850
Kong, X., Thimmulappa, R., Kombairaju, P. & Biswal, S. NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice. The Journal of Immunology 185, 569-577 (2010). https://doi.org/10.4049/jimmunol.0902315
Koide, N. et al. Lipopolysaccharide enhances interferon-γ-induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation. Journal of Endotoxin Research 13, 167-175 (2007). https://doi.org/10.1177/0968051907080894
Jin, J., Zhang, H., Weyand, C. M. & Goronzy, J. J. Lysosomes in T Cell Immunity and Aging. Frontiers in Aging 2 (2021). https://doi.org/10.3389/fragi.2021.809539
Chattopadhyay, A. et al. IFN-γ lowers tumor growth by increasing glycolysis and lactate production in a nitric oxide-dependent manner: implications for cancer immunotherapy. Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1282653
Zhang, Z. et al. Role of lysosomes in physiological activities, diseases, and therapy. Journal of Hematology & Oncology 14 (2021). https://doi.org/10.1186/s13045-021-01087-1
Liu, G., Zhang, L. & Zhao, Y. Modulation of immune responses through direct activation of Toll-like receptors to T cells. Clin Exp Immunol 160, 168-175 (2010). https://doi.org/10.1111/j.1365-2249.2010.04091.x
Downloads
Additional Files
Published
How to Cite
Issue
Section
